EXAGEN INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
EXAGEN INC. (XGN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 10.03 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-04
- EXAGEN INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-12-31 was 50.00 shares.
- EXAGEN INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-09-30 was 37.55K shares.
- EXAGEN INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-06-30 was 93.10K shares.
- EXAGEN INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-03-31 was 1.22K shares.
- EXAGEN INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 131.92K shares, a 71.21% decline from fiscal 2024.
- EXAGEN INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 458.28K shares, a 23.63% increase from fiscal 2023.
- EXAGEN INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 370.69K shares, a 142.39% increase from fiscal 2022.
- EXAGEN INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 152.93K shares, a 201.83% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 10.03K shares 10-Q · filed 2026-08-04 | |||
| 2025-12-31 | 50.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 37.60K shares derived: sum of 2 quarters · filed 2026-03-10 | 130.70K shares derived: sum of 3 quarters · filed 2026-03-10 | 131.92K shares 10-K · filed 2026-03-10 |
| 2025-09-30 | 37.55K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | 130.65K shares derived: sum of 2 quarters · filed 2025-11-04 | 131.87K shares 10-Q · filed 2025-11-04 | |
| 2025-06-30 | 93.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | 94.32K shares 10-Q · filed 2025-07-29 | ||
| 2025-03-31 | 1.22K shares 10-Q · filed 2025-05-05 | |||
| 2024-12-31 | 458.28K shares 10-K · filed 2025-03-11 | |||
| 2023-12-31 | 370.69K shares 10-K · filed 2024-03-18 | |||
| 2022-12-31 | 152.93K shares 10-K · filed 2023-03-20 | |||
| 2021-12-31 | 50.67K shares 10-K · filed 2022-03-22 | |||
| 2020-12-31 | 131.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | 173.00 shares derived: sum of 2 quarters · filed 2021-03-16 | 9.43K shares derived: sum of 3 quarters · filed 2021-03-16 | 9.85K shares 10-K · filed 2021-03-16 |
| 2020-09-30 | 42.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | 9.30K shares derived: sum of 2 quarters · filed 2020-11-10 | 9.72K shares 10-Q · filed 2020-11-10 | 10.05K shares derived: sum of 4 quarters · filed 2020-11-10 |
| 2020-06-30 | 9.26K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | 9.68K shares 10-Q · filed 2020-07-28 | 10.00K shares derived: sum of 3 quarters · filed 2020-07-28 | |
| 2020-03-31 | 417.00 shares 10-Q · filed 2020-05-11 | 743.00 shares derived: sum of 2 quarters · filed 2020-05-11 | ||
| 2019-12-31 | 326.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | 479.00 shares 10-K · filed 2020-03-25 | ||
| 2019-09-30 | 153.00 shares 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |